Relaciones entre patrón de consumo de cibersexo, control inhibitorio y nivel de satisfacción sexual en hombres / Relationships between cyber sex consumption patterns, inhibitory control and level of sexual satisfaction in men

El consumo de Cibersexo puede generar adicción en usuarios de internet, pudiendo estar relacionado con el funcionamiento ejecutivo y satisfacción sexual de estos. Se pretende analizar la relación entre consumo de cibersexo, control inhibitorio y satisfacción sexual en 120 hombres entre 20 y 29 años, mediante el Internet Sex Screening Test, la prueba de Stroop y un Cuestionario de Bienestar Sexual. Los resultados, indicaron un alto consumo de riesgo (20,8%) y adictivo (6,7%). Se obtuvo una relación positiva entre control inhibitorio y bienestar sexual (rho=2,94; p <,001) y una relación negativa entre bienestar sexual y consumo de cibersexo (rho=-0,21; p <,019). No existió asociación entre patrones adictivos de consumo de cibersexo y control inhibitorio. Al comparar patrones de consumo de cibersexo, se aprecian diferencias significativas en el bienestar emocional (H=8,15; p <,043) presentando los consumidores recreativos mayor satisfacción. Los resultados permiten informar sobre tópicos poco estudiados en Chile, destacando el alto consumo de cibersexo y la ausencia de relación entre control inhibitorio y el consumo de cibersexo, al menos no en presencia de estímulos relacionados al cibersexo. (AU)

The use of Cybersex can generate addiction in internet users and may be related to their executive functioning and sexual satisfaction. The objective is to analyze the relationship between cybersex consumption, inhibitory control and sexual satisfaction in 120 men between 20 and 29 years old, through the Internet Sex Screening Test, the Stroop test and a Sexual Wellbeing Questionnaire. The results indicated a high level of risky (20.8%) and addictive (6.7%) consumption. A positive relationship was obtained between inhibitory control and sexual well-being (rho =2.94; p <.001) and a negative relationship between sexual well-being and cybersex consumption (rho =-0.21; p <.019). There was no association between addictive patterns of cybersex consumption and inhibitory control. When comparing cybersex consumption patterns, significant differences in emotional well-being (H = 8.15; p <.043) were observed, with recreational consumers presenting greater satisfaction. The results allow us to report on topics scarcely studied in Chile, highlighting the high consumption of cybersex and the absence of a relationship between inhibitory control and cybersex consumption, at least not in presence of stimuli related to cybersex. (AU)

Effects of Behavioral Activation on the Quality of Life and Emotional State of Lung Cancer and Breast Cancer Patients During Chemotherapy Treatment.

Research suggests that the progressive abandonment of activities in cancer patients are related to depression and worse quality of life. Behavioral activation (BA) encourages subjects to activate their sources of reinforcement and modify the avoidance responses. This study assesses the effectiveness of BA in improving quality of life and preventing emotional disorders during chemotherapy treatment. One sample of lung cancer patients and another of breast cancer patients were randomized into a BA experimental group (E.G.lung/4sess.n = 50; E.G.breast/6sess.n = 33) and a control group (C.G.lung/4sess.n = 40; C.G.breast/6sess.n = 35), respectively. In each session and in follow-ups (3/6/9 months), all participants completed different assessment scales. The results converge to show the effectiveness of BA, encouraging cancer patients to maintain rewarding activities which can activate their sources of day-to-day reinforcement and modify their experience avoidance patterns. BA appears to be a practical intervention which may improve social and role functioning and the emotional state of cancer patients during chemotherapy treatment.

Efectos de la activación conductual en la calidad de vida y estado emocional / Effects of the behavioral activation in the life quality and emotional state for lung cancer patients

Objetivo: Desde un análisis contextual-funcional de los problemas/limitaciones del paciente oncológico, se valora el efecto en la calidad de vida y estado emocional de una intervención centrada en la Activación Conductual con enfermos de cáncer de pulmón durante el tratamiento oncológico. Método: 90 pacientes de reciente diagnóstico fueron asignados aleatoriamente a una condición experimental (G.E.: N=50) de 4 sesiones individuales orientadas a restablecer actividades relevantes, eliminar conductas de enfermedad y modificar el patrón de evitación experiencial; y a una condición control (G.C.: N=40) que ocupó el mismo número de sesiones en la evaluación de la calidad de vida sin ofrecer asesoramiento o tratamiento psicológico. Todos los participantes completaron, en cada sesión y en seguimiento trimestral, las escalas QLQ-C30, HAD, IK, EG y SP. Se empleó un diseño de medidas parcialmente repetidas. La evolución y tendencia de las variables se realizó mediante MLG y MLM. Resultados: Los participantes resultaron representativos de la población estudiada y no difirieron entre ellos en el pre-tratamiento. En ambos grupos se produjo una pérdida elevada de sujetos por hospitalización/fallecimiento. El G.E. mostró, a lo largo del tiempo, mejoría estadísticamente significativa (p<0,05) en todas las subescalas del QLQ-C30. En las subescalas HAD, se alcanzaron diferencias significativasentre grupos a favor del G.E (p<0,05). Los beneficios del G.E. se debilitaron en el seguimiento. El GC no experimentó cambios. Conclusiones: Se aportan evidencias del interés de los objetivos y procedimientos de Activación Conductual para mejorar, durante el tratamiento oncológico, la calidad de vida y estado emocional. Se señala la necesidad de indagar las características de los pacientes y/o de la intervención de las que depende su eficacia y eficiencia

Objective: Based on a functional-contextual analysis of the problems cancer patients have, the efficacy of Behavioral Activation Therapy for the prevention of emotional disorders and the promotion of life quality on lung cancer patients will be analyzed. Method: A total of 90 lung cancer patients were selected consecutively. Patients were randomly assigned to un experimental group (G.E.: N=50) where a specific protocol was designed to increase relevant activities and healthy behaviors, erasing disease behaviors previously learned and modifying the pattern of experiential avoidance; and a control group (G.C.: N=40) where life quality and psychosocial effects of both illness and treatment were assessed, without ever offering counseling or psychological treatment. Both conditions received a total of four individual one hour long treatment sessions in the hospital. Results were collected through standardized scales (IK, HADS, QLQ-C30, EG y SP) in each of the treatment sessions and during the three months follow-ups. The evolution and tendency of the variables was analyzed using MLG y MLM. Results: Participants, doe to their clinical and sociodemographic characteristics resulted a representative group of the population studied and did not differ between themselves in the pre-treatment. In both groups there was a loss of subjects produced by hospitalization / death. The comparison analysis inter and intra groups indicate that among participants, the G. E. showed, over time, statistically significant differences (p< 0.05) in all subscales of QLQ- C30 functioning. In the HAD subscales, significant differences between groups in favor of GE (p<0.05) were achieved. Improvements shown by the G.E. weakened during the follow-up. Conclusions: Behavioral Activation Therapy, during cancer treatment, improved life qualityand emotional adjustment. The study indicates the need to investigate the characteristics of patients and/or intervention, as its effectiveness and efficiency depends on them

Influencia del estado emocional en la sintomatología referida por pacientes con cáncer de mama y cáncer de pulmón durante el tratamiento con quimioterapia / The influence of the emotional state on the physical symptoms of patients with breast and lung cancer during chemotherapy treatment

Analizar la evolución de los síntomas físicos y emocionales y la influencia de la ansiedad y la depresión en el estado físico de los pacientes con cáncer de pulmón o cáncer de mama a lo largo del tratamiento con quimioterapia intravenosa (QT).Método Sesenta y seis pacientes, 29 con cáncer de mama y 37 con cáncer de pulmón, fueron evaluados antes de iniciar el tratamiento, finalizado el primero, segundo y último ciclo de QT, mediante el HAD y un cuestionario de síntomas. Resultados La ansiedad se redujo significativamente al finalizar el tratamiento en todos los participantes pero la depresión solo disminuyó en los pacientes con cáncer de pulmón. Durante el tratamiento se incrementó significativamente la astenia, la disnea y las náuseas. El insomnio disminuyó a lo largo del tiempo en los pacientes con cáncer de pulmón y se incrementó en los pacientes con cáncer de mama. Al eliminar la varianza compartida con ansiedad y depresión, se comprobó que la mayoría de los cambios en los síntomas fueron atribuibles a los factores tiempo y tipo de cáncer. Conclusiones El estado emocional no parece influir significativamente, durante el tratamiento con QT, en la presencia e intensidad de la sintomatología (AU)

Aim to analyse the evolution of the physical and emotional symptoms, and the influence of anxiety and depression on the physical state of breast or lung cancer sufferers during treatment with intravenous chemotherapy (CT).Method A total of 66 patients, 29 suffering from breast cancer and 37 suffering from lung cancer, were evaluated before the treatment, and after completing the first, second and last cycle of CT using the Hospital Anxiety and Depression (HAD) and the Symptoms Questionnaires. Results Anxiety was reduced greatly in all patients once the treatment was over, but depression was only reduced in lung cancer sufferers. Throughout the treatment, fatigue, dyspnea and nausea significantly increased in all patients. Sleeplessness decreased over time in patients with lung cancer, but increased in those patients with breast cancer. By introducing the HAD scores as covariables, it was found that most of the differences were due to the time factor and the type of cancer. Conclusions During treatment with intravenous chemotherapy (CT), the emotional state does not seem to have a significant influence on the presence and severity of the symptoms (AU)

Repercusión de la ansiedad y depresión en el estado físico y funcionalidad de enfermos oncológicos durante el tratamiento con quimioterapia / Impact of anxiety and depression on the physical status and daily routines of cancer patients during Chemotherapy

Se describe la evolución de la sintomatología, estado emocional y rutinas cotidianas en pacientes con cáncer de mama y cáncer de pulmón durante el tratamiento con quimioterapia (QT), y se analiza la mediación de la ansiedad y depresión en el estado físico y funcionalidad. 66 pacientes, 29 con cáncer de mama y 37 con cáncer de pulmón, se evalúan antes de iniciar el tratamiento, finalizado el primero, segundo y último ciclo de QT, mediante el HAD, escalas de apreciación y entrevista. Menos de un 30% alcanzan puntuaciones en el HAD indicativas patología ansiosa o depresiva. Se incrementó significativamente el cansancio, fatiga y náuseas y se interrumpen las actividades laborales y de ocio. La preocupación por el futuro de allegados y el insomnio se incrementan significativamente a lo largo del tiempo en pacientes con cáncer de mama, mientras que se reducen en pacientes con cáncer de pulmón. Al introducir como covariables las puntuaciones obtenidas en el HAD, se comprueba que la mayoría de diferencias son atribuibles a los factores tiempo y tipo de cáncer. Las alteraciones emocionales no parecen tener, durante el tratamiento con QT, un peso relevante en la sintomatología y cambios en la vida cotidiana referidos por el paciente oncológico (AU)

The evolution of symptoms, emotional state and daily routines in patients with breast cancer and lung cancer during treatment with intravenous chemotherapy (CT) is described and the influence of anxiety and depression on these variables is analyzed. 66 patients, 29 with breast cancer and 37 with lung cancer, were evaluated before starting treatment, and after completing the first, second and last cycle of CT using the Hospital Anxiety and Depression Scale (HADS), rating scales and interview. Less than 30% of the patients showed clinical anxiety or depression according to the HADS. Throughout the treatment, tiredness, fatigue and nausea increased significantly and work and leisure activity decreased. Concern about the future of relatives and insomnia increased significantly over time in patients with breast cancer whereas they decreased in patients with lung cancer. By introducing the HADS scores as covariates, it was found that most differences are due to the time factor and the type of cancer. During treatment with CT, emotional disturbances do not seem to have significant impact on the symptoms and changes in daily life reported by cancer patients (AU)

[Impact of anxiety and depression on the physical status and daily routines of cancer patients during chemotherapy]. / Repercusión de la ansiedad y depresión en el estado físico y funcionalidad de enfermos oncológicos durante el tratamiento con quimioterapia.

The evolution of symptoms, emotional state and daily routines in patients with breast cancer and lung cancer during treatment with intravenous chemotherapy (CT) is described and the influence of anxiety and depression on these variables is analyzed. 66 patients, 29 with breast cancer and 37 with lung cancer, were evaluated before starting treatment, and after completing the first, second and last cycle of CT using the Hospital Anxiety and Depression Scale (HADS), rating scales and interview. Less than 30% of the patients showed clinical anxiety or depression according to the HADS. Throughout the treatment, tiredness, fatigue and nausea increased significantly and work and leisure activity decreased. Concern about the future of relatives and insomnia increased significantly over time in patients with breast cancer whereas they decreased in patients with lung cancer. By introducing the HADS scores as covariates, it was found that most differences are due to the time factor and the type of cancer. During treatment with CT, emotional disturbances do not seem to have significant impact on the symptoms and changes in daily life reported by cancer patients.